Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024

Industry Insights

The global nephrology and urology devices market size was estimated at USD 18.03 billion in 2016 and is expected to develop at a CAGR of 7.1% over the forecast period. Increasing prevalence of kidney failure and end-stage renal diseases has resulted in clinical urgency for devices that can improve existing patient outcomes and curb long-term costs associated with treatment of kidney diseases.

In addition, widening geriatric population base, which is highly susceptibility to these diseases, is expected to spur demand in the coming years. According to a research published in Medscape, kidney failure is one of the major causes for high mortality rate in the U.S. As mentioned in a research published in NCBI, end-stage renal disease is a major cost driver in most healthcare systems across developed economies. As a result, rising awareness pertaining to renal replacements in these economies is presumed to provide lucrative growth opportunities in the market.

The market is driven by technological advancements in these devices such as extracorporeal shockwave lithotripsy, percutaneous methods for stone disintegration and extraction, and inclusion of prosthetics in urology. These technologies have resulted in improved capacities in kidney and urinary stone management and cater to larger patient volumes due to reduced treatment duration and recovery time. These technologies also reduce the probability of recurrence of stone formation and are being increasingly incorporated in pediatric urology.

Type Insights

Dialysis equipment held the dominant revenue share in the nephrology and urology devices market as of 2015. This is a consequence of high clinical urgency to curb unprecedented growth in renal failure globally. In addition, factors such as large procedural volumes, wide range availability, and relatively higher patient awareness levels are expected to help the segment maintain its dominant position throughout the forecast period. Moreover, easy availability and presence of a wide-scale portfolio are facilitating greater penetration of dialysis equipment, thus resulting in a larger market share.

Benign prostatic hyperplasia (BPH) is anticipated to witness lucrative growth over the forecast period owing to potential benefits associated with nephrology and urology devices in treatment of BPH as well as consistent advancements in these devices. In addition, innovation in surgical procedures has resulted in a lower morbidity rate, thus widening the scope for this segment.

The segment is also fueled by the ability of personalized medicine to cater to individual needs. Technological advancements such as inclusion of bipolar resectors, laser vaporization, and robotic prostatectomy are also anticipated to fuel demand for these devices in the coming years.

Regional Insights

Europe held a dominant share in the market in 2015. The presence of prominent players, advanced healthcare infrastructure, high disposable income, and patients’ willingness and ability to pay are some of the factors responsible for this region’s growth.

The Asia Pacific market is anticipated to witness lucrative growth in the coming years due to increasing healthcare expenditure levels, rising awareness related to kidney and urinary tract disorders, and improving healthcare facilities in the region. Moreover, urgent need for development of new systems and replacing and upgrading existing medical infrastructure are other factors attributed to growing demand for these devices.

Nephrology and Urology Devices Market Share Insights

The industry is highly consolidated in nature and is marked by the presence of prominent players undertaking strategies such as mergers and acquisitions, new product launch, R&D investments, and geographical expansions. Some of the most notable participants are Fresenius Medical Care; Baxter International; Boston Scientific; C.R. Bard Inc.; Cook Medical; and Dornier MedTech.

Industry leaders are involved in extensive activities for research and development of cost-efficient and highly advanced systems such as extracorporeal shock wave lithotripters. Subsequently, introduction of such efficient products is expected to provide lucrative opportunities.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the global nephrology and urology devices market report on the basis of type and region:

• Type Outlook (Revenue, USD Billion, 2013 - 2024)

  • Dialysis

  • Urinary Stone

    • Ureteral stents

    • Lithotripters

  • Urinary Incontinence & Pelvic Organ Prolapsed

    • Sacral neuromodulation

    • Vaginal meshes & slings

    • Ureteral inserts & pessaries

  • Benign Prostatic Hyperplasia

    • Catheter ablation

    • Prostatic stents

  • Endoscopy

  • Others

• Regional Outlook (Revenue, USD Billion, 2013 - 2024)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

    •  India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa